Nocturia Clinical Trial
Official title:
Minirin Melt Tolerance With Nocturia in the Common Practice Conditions in Czech Republic
| Verified date | October 2012 |
| Source | Ferring Pharmaceuticals |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Czech Republic: State Institute for Drug Control |
| Study type | Observational |
This is a confirmation of safety profile for Minirin Melt in clinical practice.
| Status | Completed |
| Enrollment | 588 |
| Est. completion date | March 2011 |
| Est. primary completion date | December 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 64 Years |
| Eligibility |
Inclusion Criteria: - patients suffering from Nocturia Exclusion Criteria: - habitual or psychogenic polydipsia - known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics - moderate and severe renal insufficiency - know hyponatremia - syndrome of inappropriate ADH secretion |
Time Perspective: Retrospective
| Country | Name | City | State |
|---|---|---|---|
| Czech Republic | Hospital Šumperk | Šumperk | |
| Czech Republic | Private Ambulance | Blansko | |
| Czech Republic | Private Ambulance | Brno | |
| Czech Republic | Trauma Hospital in Brno | Brno | |
| Czech Republic | Urocentrum | Brno | |
| Czech Republic | Uromeda, s.r.o. | Brno | |
| Czech Republic | Private Ambulance | Brno-Zábrdovice | |
| Czech Republic | Private Ambulance | Bystrice pod Hostýnem | |
| Czech Republic | Hospital Decín | Decín | |
| Czech Republic | University Hospital Hradec Králové | Hradec Králové | |
| Czech Republic | Hospital Jablonec nad Nisou | Jablonec nad Nisou | |
| Czech Republic | Hospital Jihlava | Jihlava | |
| Czech Republic | Hospital Kromeríž | Kromeríž | |
| Czech Republic | Polyclinic Kurim | Kurim | |
| Czech Republic | Private Ambulance | Moravský Krumlov | |
| Czech Republic | Hospital Nové Mesto na Morave | Nové Mesto na Morave | |
| Czech Republic | Hospital with Polyclinic Nový Jicín | Nový Jicín | |
| Czech Republic | Private Ambulance | Nový Jicín | |
| Czech Republic | University Hospital Olomouc | Olomouc | |
| Czech Republic | City Hospital Ostrava | Ostrava | |
| Czech Republic | Hospital Ostrava | Ostrava | |
| Czech Republic | Private Ambulance | Ostrava | |
| Czech Republic | Central Military Hospital | Prague | |
| Czech Republic | Medicon, s.r.o. | Prague | |
| Czech Republic | Polyclinic Barandov | Prague | |
| Czech Republic | Railway Hospital | Prague | |
| Czech Republic | Thomayer´s Hospital | Prague | |
| Czech Republic | University Hospital Bulovka | Prague | |
| Czech Republic | Private Ambulance | Prague 10 | |
| Czech Republic | Private Ambulance | Praha 4 | |
| Czech Republic | Private Ambulance | Prerov | |
| Czech Republic | Hospital Prostejov | Prostejov | |
| Czech Republic | Private Ambulance | Trebíc | |
| Czech Republic | Hospital Uherské Hradište | Uherské Hradište | |
| Czech Republic | Hospital Ústí nad Orlicí, Inc | Ústí nad Orlicí | |
| Czech Republic | Hospital Valašské Mezirící, Inc | Valašské Mezirící | |
| Czech Republic | T. Bata Regional Hospital, Inc. | Zlín | |
| Czech Republic | Hospital Znojmo | Znojmo |
| Lead Sponsor | Collaborator |
|---|---|
| Ferring Pharmaceuticals |
Czech Republic,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of participants with adverse events | 12 months | Yes | |
| Secondary | Number of participants with nocturnal voiding | 12 months | No | |
| Secondary | Number of participants with adverse events | 12 months | Yes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03623880 -
Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders
|
N/A | |
| Completed |
NCT02905682 -
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
|
Phase 3 | |
| Completed |
NCT02835846 -
Investigation of the Effect of the Female Urinary Microbiome on Incontinence
|
Phase 4 | |
| Completed |
NCT02904759 -
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
|
Phase 3 | |
| Completed |
NCT01694498 -
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men
|
Phase 2 | |
| Completed |
NCT01684800 -
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
|
Phase 2 | |
| Completed |
NCT01520948 -
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
|
Phase 3 | |
| Recruiting |
NCT04305743 -
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
|
Phase 4 | |
| Completed |
NCT01486706 -
Efficacy and Safety of Gabapentin in Treating Overactive Bladder
|
Phase 2/Phase 3 | |
| Completed |
NCT04528784 -
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT05874375 -
UCon Treatment of Overactive Bladder (OAB) in Males
|
N/A | |
| Completed |
NCT01223937 -
Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients
|
Phase 3 | |
| Withdrawn |
NCT01018225 -
Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness
|
Phase 4 | |
| Completed |
NCT05222477 -
Abdominal Muscle Exercises on Nocturia and Sleep Quality in Women With Type 2 Diabetes
|
N/A | |
| Withdrawn |
NCT02961114 -
Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy
|
Phase 1/Phase 2 | |
| Completed |
NCT02440841 -
Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon
|
Phase 1 | |
| Completed |
NCT02068560 -
The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion
|
N/A | |
| Completed |
NCT02151253 -
Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
|
Phase 2/Phase 3 | |
| Completed |
NCT01357356 -
Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia
|
Phase 2/Phase 3 | |
| Completed |
NCT00700583 -
Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men
|
N/A |